We should be seeing more of these studies over time. This data mining study found that one type of FM patient - people with
- Resource Type:
- Report or Study
- high pain levels
- low anxiety or catastrophizing
- no major sleep problems, absence of major sleeping problems
- physical limitations in the daily life effort
benefited most from milnacipran (Savella) - an FDA approved drug for FM. That's important because only a subset of patients benefit.